Review
Open access
Aug 2026
De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD
Treatment de-escalation is sometimes necessary because of adverse effects, comorbidities, infections, treatment fatigue, or life circumstances such as pregnancy, but in pregnancy, management requires balancing maternal disease control with fetal safety, with strategies ranging from continuation of selected therapies to...
Y. Hacohen, G. Androdias, G. Arrambide et al.
· Neurology · 0 citations